GGTI 298 trifluoroacetate salt hydrate ≥90% (HPLC), film ยี่ห้อ Sigma

PROPERTIES

Quality Level

100

Assay

≥90% (HPLC)

form

film

lyophilized

impurities

<10% dimer

color

colorless

mp

99.5-100 °C

solubility

DMSO: >20 mg/mL

storage temp.

−20°C

SMILES string

OC(=O)C(F)(F)F.COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c2cccc3ccccc23

InChI

1S/C27H33N3O3S.C2HF3O2/c1-17(2)13-25(27(32)33-3)30-26(31)23-12-11-20(29-15-19(28)16-34)14-24(23)22-10-6-8-18-7-4-5-9-21(18)22;3-2(4,5)1(6)7/h4-12,14,17,19,25,29,34H,13,15-16,28H2,1-3H3,(H,30,31);(H,6,7)/t19-,25+;/m1./s1

InChI key

WALKWJPZELDSKT-UFABNHQSSA-N

Gene Information

human ... PGGT1B(5229)

DESCRIPTION

Application

GGTI 298 trifluoroacetate salt hydrate has been used as a geranylgeranyltransferase I (GGTase I) inhibitor:

to study the anticancer effects of statins along with GGTI 298[1]

to study its combinatorial effects with FTI-277 on statin-mediated activation of extracellular signal-regulated kinase 5 (ERK5) in the human endothelium[2]

to evaluate the effect of protein geranylgeranylation (GG) inhibition on the breast cancer stem cell (CSC) population[3]

Biochem/physiol Actions

GGTI 298 is a cell-permeable, prodrug form of the geranylgeranyltransferase I (GGTase I) inhibitor GGTI-297. It inhibits the processing of Rap 1A without effecting the processing of H-Ras.

Features and Benefits

This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.